# Müllerian papilloma: two case reports of malignant transformation and literature review

**Authors:** Sirong Tao, Yan Zhang, Wei Wang, Ying He, Lili Jiang

PMC · DOI: 10.3389/fonc.2025.1573747 · 2025-07-31

## TL;DR

This paper reports two rare cases of Müllerian papilloma turning cancerous in young girls and explores their unique molecular features.

## Contribution

First use of next-generation sequencing to analyze molecular characteristics of Müllerian papilloma malignant transformation.

## Key findings

- Malignant transformation of Müllerian papilloma into endometrioid carcinoma was confirmed in two young patients.
- NGS identified three novel fusion genes and revealed low tumor mutation burden with stable microsatellites.
- Pathological features included complex papillary structures, cribriform patterns, and high ki67 proliferation index.

## Abstract

Müllerian papilloma is a rare benign genital tract tumor, and its malignant transformation is extremely rare. Due to its complex and diverse pathological morphological manifestations, it is prone to misdiagnosis.

We reported the malignant transformation of Müllerian papilloma into endometrioid carcinoma in two young girls, along with their pathological results. For the first time, we combined next-generation sequencing (NGS) technology to explore the molecular characteristics.

The two cases of malignant transformation into endometrioid adenocarcinoma exhibited similar pathological morphology and immunohistochemical (IHC) markers. Morphologically, they presented complex and diverse features. The benign areas showed a mild papillary structure, while the malignant areas displayed complex papillary branches, cribriform patterns, and solid structures, accompanied by hemorrhage, necrosis, and interstitial inflammatory cell infiltration. In terms of IHC, CK7 and EMA were either focally positive or diffusely positive; Vimentin, P16, and SALL-4 were negatively expressed; P53 showed wild-type expression; the ki67 proliferation index was 35-45%. Subsequent sequencing revealed a low tumor mutation burden and stable microsatellites. However, three novel fusion genes were identified.

The malignant transformation of Müllerian papilloma is extremely rare, with complex and diverse morphological manifestations. High vigilance is required during diagnosis to avoid confusion with sarcomas. This tumor has a low tumor mutation burden and stable microsatellites, and the exact mechanism of malignant transformation requires further investigation.

## Linked entities

- **Genes:** TP53 (tumor protein p53) [NCBI Gene 7157], CDKN2A (cyclin dependent kinase inhibitor 2A) [NCBI Gene 1029], SALL4 (spalt like transcription factor 4) [NCBI Gene 57167], KRT7 (keratin 7) [NCBI Gene 3855], ETFA (electron transfer flavoprotein subunit alpha) [NCBI Gene 2108], PRELID1 (PRELI domain containing 1) [NCBI Gene 737446]
- **Diseases:** endometrioid carcinoma (MONDO:0005026), endometrioid adenocarcinoma (MONDO:0005026)

## Full-text entities

- **Genes:** CDKN2A (cyclin dependent kinase inhibitor 2A) [NCBI Gene 1029] {aka ARF, CAI2, CDK4I, CDKN2, CMM2, INK4}, KRT7 (keratin 7) [NCBI Gene 3855] {aka CK7, K2C7, K7, SCL}, TP53 (tumor protein p53) [NCBI Gene 7157] {aka BCC7, BMFS5, LFS1, P53, TRP53}, SALL4 (spalt like transcription factor 4) [NCBI Gene 57167] {aka DRRS, HSAL4, IVIC, ZNF797}, MUC1 (mucin 1, cell surface associated) [NCBI Gene 4582] {aka ADMCKD, ADMCKD1, ADTKD2, CA 15-3, CD227, Ca15-3}, VIM (vimentin) [NCBI Gene 7431]
- **Diseases:** necrosis (MESH:D009336), hemorrhage (MESH:D006470), tumor (MESH:D009369), endometrioid adenocarcinoma (MESH:D018269), sarcomas (MESH:D012509), genital tract tumor (MESH:D060737), Mullerian papilloma (MESH:D010212), inflammatory (MESH:D007249)

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12350135/full.md

---
Source: https://tomesphere.com/paper/PMC12350135